What Happened?
, -based GenomeDx Biosciences Promoted Ryen MacDonald as Director, Marketing
About the Company
Delivering Genomic Tests that Impact Treatment Decisions GenomeDx develops and commercializes genomic tests for prostate and other urologic cancers that have a direct impact on treatment decision-making, improve patient outcomes and ultimately reduce healthcare costs.
About the Person
Ryen MacDonald is Director, Marketing at GenomeDx Biosciences. Previously, Ryen held various senior HR leadership roles in the industry.
Info Source
News
Short Profile